Expression of the influenza M2 protein in three different eukaryotic cell lines

Journal of Virological Methods

Volumn 179, Issue 1, 2012, Pages 161-165

  Esghaei, Maryam ^a   Monavari, Seyed Hamid Reza ^a   Tavassoti Kheiri, Masoumeh ^b   Shamsi Shahrabadi, Mahmoud ^a   Heydarchi, Behnaz ^b   Farahmand, Behrokh ^b   Saleh, Maryam ^b   Fotouhi, Fatemeh ^b  

^a TEHRAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Eukaryotic cells; Expression; Influenza A virus; Recombinant M2 protein

Indexed keywords

DNA VACCINE; PROTEIN M2; RECOMBINANT PROTEIN;

ANTIGEN PURIFICATION; ARTICLE; CELL STRAIN; CELL STRAIN COS7; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETIC TRANSFECTION; HELA CELL; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE TEST; INFLUENZA VIRUS A H1N1; M2 GENE; MOLECULAR CLONING; MOUSE; NONHUMAN; PLASMID; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; VIRUS GENE; WESTERN BLOTTING;

ANIMALS; CELL LINE; CERCOPITHECUS AETHIOPS; DOGS; EUKARYOTIC CELLS; GENE EXPRESSION; GENETIC VECTORS; HUMANS; PLASMIDS; RECOMBINANT PROTEINS; VIRAL MATRIX PROTEINS;

EUKARYOTA; INFLUENZA A VIRUS; ORTHOMYXOVIRIDAE;

EID: 84855221817     PISSN: 01660934     EISSN: 18790984     Source Type: Journal    
DOI: 10.1016/j.jviromet.2011.10.016     Document Type: Article

References (32)

1. Betakova T. M2 protein - a proton channel of influenza A virus. Curr. Pharm. Des. 2007, 13:3231-3235.
2. Carrat F., Flahault A. Influenza vaccine: the challenge of antigenic drift. Vaccine 2007, 25:6852-6862.
3. Chu C., Lugovtsev V., Golding H., Betenbaugh M., Shiloach J. Conversion of MDCK cell line to suspension culture by transfecting with human siat7e gene and its application for influenza virus production. Proc. Natl. Acad. Sci. U.S.A. 2009, 106:14802.
4. Donaldson L.J., Rutter P.D., Ellis B.M., Greaves F.E.C., Mytton O.T., Pebody R.G., Yardley I.E. Mortality from pandemic A/H1N1 2009 influenza in England: public health surveillance study. Br Med J 2009, 339.
5. Ebrahimi S.M., Tebianian M., Toghyani H., Memarnejadian A., Attaran H.R. Cloning, expression and purification of the influenza A (H9N2) virus M2e antigen and truncated Mycobacterium tuberculosis HSP70 as a fusion protein in Pichiapastoris. Protein Expr. Purif. 2010, 70:7-12.
6. Feng J.Q., Zhang M., Mozdzanowska K., Zharikova D., Hoff H., Wunner W., Couch R.B., Gerhard W. Influenza A virus infection engenders a poor antibody response against the ectodomain of matrix protein 2. Virol. J. 2006, 3:102.
7. Fiers W., De Filette M., Bakkouri K.E., Schepens B., Roose K., Schotsaert M., Birkett A., Saelens X. M2e-based universal influenza A vaccine. Vaccine 2009, 27:6280-6283.
8. Fiers W., De Filette M., Birkett A., Neirynck S., Min Jou W. A " universal" human influenza A vaccine. Virus Res. 2004, 103:173-176.
9. Furuse Y., Suzuki A., Kamigaki T., Oshitani H. Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol. J. 2009, 6:67.
10. Grandea A., Olsen r., Cox O., Renshaw T., Hammond M., Chan-Hui P., Mitcham P., Cieplak J.W. Human antibodies reveal a protective epitope that is highly conserved among human and nonhuman influenza A viruses. Proc. Natl. Acad. Sci. U.S.A. 2010, 107:12658.
11. Heiny A., Miotto O., Srinivasan K.N., Khan A.M., Zhang G., Brusic V., Tan T.W., August J.T. Evolutionarily conserved protein sequences of influenza a viruses, avian and human, as vaccine targets. PLoS One 2007, 2:e1190.
12. Hossain M.J., Perez S., Guo Z., Chen L.M., Donis R.O. Establishment and characterization of a Madin-Darby canine kidney reporter cell line for influenza A virus assays. J. Clin. Microbiol. 2010, 48:2515.
13. Huang I.C., Li W., Sui J., Marasco W., Choe H., Farzan M. Influenza A virus neuraminidase limits viral superinfection. J. Virol. 2008, 82:4834-4843.
14. Liu W., Zou P., Chen Y.H. Monoclonal antibodies recognizing EVETPIRN epitope of influenza A virus M2 protein could protect mice from lethal influenza A virus challenge. Immunol. Lett. 2004, 93:131-136.
15. Lo C.Y., Wu Z., Misplon J.A., Price G.E., Pappas C., Kong W.P., Tumpey T.M., Epstein S.L. Comparison of vaccines for induction of heterosubtypic immunity to influenza A virus: cold-adapted vaccine versus DNA prime-adenovirus boost strategies. Vaccine 2008, 26:2062-2072.
16. Lu B., Zhou H., Ye D., Kemble G., Jin H. Improvement of influenza A/Fujian/411/02 (H3N2) virus growth in embryonated chicken eggs by balancing the hemagglutinin and neuraminidase activities, using reverse genetics. J. Virol. 2005, 79:6763.
17. Oxford J.S., Al-Jabri A.A., Lambkin R., Palache A., Fleming D. Non-responders to egg grown influenza vaccine seroconvert after booster immunization with MDCK cell grown vaccine. Vaccine 2003, 21:2743-2746.
18. Poon L.L., Leung Y.H., Nicholls J.M., Perera P.Y., Lichy J.H., Yamamoto M., Waldmann T.A., Peiris J.S., Perera L.P. Vaccinia virus-based multivalent H5N1 avian influenza vaccines adjuvanted with IL-15 confer sterile cross-clade protection in mice. J. Immunol. 2009, 182:3063-3071.
19. Price G.E., Soboleski M.R., Lo C.Y., Misplon J.A., Pappas C., Houser K.V., Tumpey T.M., Epstein S.L. Vaccination focusing immunity on conserved antigens protects mice and ferrets against virulent H1N1 and H5N1 influenza A viruses. Vaccine 2009, 27:6512-6521.
20. Rao S.S., Kong W.P., Wei C.J., Van Hoeven N., Gorres J.P., Nason M., Andersen H., Tumpey T.M., Nabel G.J. Comparative efficacy of hemagglutinin, nucleoprotein, and matrix 2 protein gene-based vaccination against H5N1 influenza in mouse and ferret. PLoS One 2010, 5:e9812.
21. Read E.K.C., Digard P. Individual influenza A virus mRNAs show differential dependence on cellular NXF1/TAP for their nuclear export. J. Gen. Virol. 2010, 91:1290.
22. Schotsaert M., De Filette M., Fiers W., Saelens X. Universal M2 ectodomain-based influenza A vaccines: preclinical and clinical developments. Expert Rev. Vaccines 2009, 8:499.
23. Song J.M., Wang B.Z., Park K.M., Van Rooijen N., Quan F.S., Kim M.C., Jin H.T., Pekosz A., Compans R.W., Kang S.M. Influenza virus-like particles containing M2 induce broadly cross protective immunity. PLoS One 2011, 6:e14538.
24. Stech J., Stech O., Herwig A., Altmeppen H., Hundt J., Gohrbandt S., Kreibich A., Weber S., Klenk H.D., Mettenleiter T.C. Rapid and reliable universal cloning of influenza A virus genes by target-primed plasmid amplification. Nucleic Acids Res. 2008, 36:e139.
25. Tompkins S.M., Zhao Z.S., Lo C.Y., Misplon J.A., Liu T., Ye Z., Hogan R.J., Wu Z., Benton K.A., Tumpey T.M. Matrix protein 2 vaccination and protection against influenza viruses, including subtype H5N1. Emerg. Infect. Dis. 2007, 13:426.
26. Wang S., Taaffe J., Parker C., Solorzano A., Cao H., Garcia-Sastre A., Lu S. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines. J. Virol. 2006, 80:11628.
27. Wilschut J. Influenza vaccines: the virosome concept. Immunol. Lett. 2009, 122:118-121.
28. Wu C.Y., Yeh Y.C., Yang Y.C., Chou C., Liu M.T., Wu H.S., Chan J.T., Hsiao P.W. Mammalian expression of virus-like particles for advanced mimicry of authentic influenza virus. PLoS One 2010, 5:e9784.
29. Yang J.L., Wang H.L., Wang S.X., Yang P., Liu K.T., Jiang C.Y. High-level expression, purification and characterization of codon-optimized recombinant hemagglutinin 5 proteins in mammalian cells. Chin. Med. J. (Engl.) 2010, 123:1073-1077.
30. Zell R., Motzke S., Krumbholz A., Wutzler P., Herwig V., Dürrwald R. Novel reassortant of swine influenza H1N2 virus in Germany. J. Gen. Virol. 2008, 89:271.
31. Zharikova D., Mozdzanowska K., Feng J., Zhang M., Gerhard W. Influenza type A virus escape mutants emerge in vivo in the presence of antibodies to the ectodomain of matrix protein 2. J. Virol. 2005, 79:6644-6654.
32. Zou P., Liu W., Wu F., Chen Y.H. Fine epitope mapping of an antibody that binds the ectodomain of influenza matrix protein 2. FEMS Immunol. Med. Microbiol. 2008, 53:79-84.